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TABLE 1. A. Test values of patients and controls. B. Test values at baseline (atorvastatin 40 mg/day) and 3 months of study (atorvastatin
80 mg/day).
Part A Patients (n ¼ 29) Controls (n ¼ 39) P value Part B Baseline (n ¼ 26) Postintervention (n ¼ 26) P value
SUA (mg/dL) 6.0 (4.9–6.9) 5.2 (4.0–6.1) .036 6.0 (4.9–6.8) 5.8 (4.8–6.4) .018
Total cholesterol (mg/dL) 221 (228–252) 230 (204–249) .862 229 (201–258) 192 (173–217) .001
HDL-c (mg/dL) 42 (37–52) 50 (43–56) .011 42 (36–50) 42 (38–48) .517
LDL-c (mg/dL) 145 (130–174) 155 (130–177) .820 146 (131–175) 122 (95–138) .001
Triglycerides (mg/dL) 163 (97–252) 110 (77–146) .008 166 (87–250) 132 (103–194) .201
CRP (mg/dL) 0.30 (0.16–0.64) 0.15 (0.07–0.37) .019 0.32 (0.17–0.69) 0.14 (0.09–0.34) .004
n, Sample size; SUA, serum uric acid levels; HDL-c, high-density lipoprotein cholesterol; LDL-c, low-density lipoprotein cholesterol, CRP, C-reactive protein.
Letters to the Editorpreoperative statin therapy can reduce
cardiac mortality after CABG by
means of mechanisms that are inde-
pendent of their cholesterol-lowering
properties.3 We suggest that one of
these mechanisms may be the hypour-
icemic effect of statins. The underly-
ing mechanisms of this effect of
statins are not clear-cut. It has been
speculated that statins increase renal
blood flow and, thus, increase renal ur-
ate excretion and lower serum creati-
nine levels.4 According to the results
shown by Hillis and associates1 and
given that measurement of SUA is
a routine procedure with repeatable re-
sults in clinical laboratories, we pro-
pose the clinical importance of
monitoring and intervention on the ba-
sis of increased SUA levels and re-em-
phasize the positive effect of using
high doses of statins.5
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REPAIR
To the Editor:
We read with interest the article of
Sun and coworkers1 on the use of the
stented elephant trunk for type A acute
aortic dissection (TAAD). The aim of
this hybrid approach is to stabilize
the residual dissected aorta and thus
prevent late thoracoabdominal aneu-
rysm formation and the need for reop-
eration. Even though the idea is
extremely attractive, we are doubtful
that stenting the descending aorta is
really needed during TAAD repair. In-
deed, a literature review reveals that
expansion of the residual dissected
aorta after surgical repair is a slow
and linear process that makes distal re-
operations relatively uncommon. In an
article published on the same issue of
this Journal, Stevens and collegues,2of Thoracic and Cardiovascular Surgerreporting the 25-year experience of
the Massachusetts General Hospital
with 195 patients treated for TAAD,
concluded: ‘‘Aortic reoperations were
infrequent during follow-up.’’ In
another recent paper, Geirrson and
collegues3 reported that only 12 of
221 patients required late reoperation
for thoracoabdominal aneurysm.
Similarly, Dobrilovic and Elefter-
iades4 reported just 4 distal reoperation
in a series of 200 patients operated on
for TAAD.3 Taking these data into
consideration, we believe that adjunc-
tive descending endovascular stent
grafting during emergency surgical
repair might add supplementary risk
to an alredy complex procedure with
a high mortality rate, stabilizing some-
thing that has a low probability to
cause a surgical problem in the future.
In our opinion, a solution to im-
prove long-term results of TAAD is
represented by combining a radical
surgical resection with an extensive
arch debranching to create a safe and
long proximal landing zone for sub-
sequent endovascular procedures on
the descending aorta, if needed.
Our technique consists in replacing
the ascending aorta and the arch and re-
locating the origin of the supra-aortic
vessels very proximally just above the
sinotubular junction, using a specially
designed quadrifurcated vascular
prosthesis (The Plexus 4-Branch;
Vascutek Terumo Inc, Scotland, United
Kingdom). If the patient will be one of
the few who needs a second procedure
on the descending aorta, this preventive
debranching will allows a safe and
effective endovascular treatment in
both the short and the long term.y c Volume 139, Number 5 1359
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We appreciate the comments made
by Glauber and colleagues regarding
our article about surgical treatment of
acute type A dissection using the
stented elephant trunk technique.1
They thought that it was unnecessary
to implant the stented elephant trunk
into the distal aorta. They raised inter-
esting points: replace the ascending
aorta and the arch and relocate the
origin of the supra-aortic vessels very
proximally just above the sinotubular
junction. A safe and long proximal
landing zone would thereby be created
to facilitate subsequent endograft re-
pair of the distal aorta (if necessary).
In fact, the fate of the residual distal
aorta after acute type A dissection
repair is controversial. Even though
expansion of the residual aorta after sur-
gical repair is a slow and linear process
that makes distal reoperations relatively
uncommon, as recommended by their
team and others,2 a recent report dem-
onstrated that hemiarch replacement1360 The Journal of Thoracic andfor acute type A dissection had a high
mortality rate compared with total
arch replacement combined with
stented elephant trunk implantation.3
In our opinion, this might be
associated with the difference of the ex-
tent of propagation and involvement of
aortic dissection. Thuswedivided acute
type A dissection into two subtypes:
subtype C and subtype S. (1) Subtype
C (complex type) is characterized by
the primary tear located in the trans-
verse arch or the descending aorta; an-
eurysm formation in the aortic arch or
the distal aorta (40 mm); involve-
ment, aneurysm formation, and occlu-
sion of the brachiocephalic artery; or
Marfan syndrome. (2) In subtype S
(simple type), the primary tear is lo-
cated in the ascending aorta without
the features of subtype C. There was
no need to perform total arch replace-
ment.
Subtype C was associated with
a higher risk of reoperation using a con-
ventional strategy (limited ascending
aortic or hemiarch replacement). Total
arch replacement was recommended
to decrease the risk of distal reoperation
after surgery. If aortic dissection ex-
tended beyond the distal arch, a stented
elephant trunk was implanted into the
distal aorta. Implantation of a surgical
stent graft into the distal aorta involved
the following: (1) secure the anastomo-
sis; (2) simplify total arch replacement;
(3) promote thrombosis of the false lu-
men in the distal aorta; (4) enlarge the
true lumen; (5) and facilitate the later
thoracoabdominal aortic replacement,
if necessary.
As for the authors’ interesting
approach, several issues should be
raised. Compared with the antegrade
intraoperative surgical stent, it is trou-
blesome to deliver the stent graft ret-
rogradely via the femoral artery.
Because there is no extravascular
graft of the end of the stent graft to
be used for sewing, it is difficult to
manage if a late distal aortic reopera-
tion is needed. The complications of
the endovascular treatment cannot be
prevented either.Cardiovascular Surgery c May 2010LiZhong Sun, MDa
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ALWAYS NECESSARY?
To the Editor:
Congratulations to Brancaccio and
colleagues1 for this valuable study.
The reported surgical technique stated
that transannular patch plasty was
performed in patients with a pulmo-
nary valve Z-score less than2. How-
ever, we have two questions: Did the
authors think about the septal excision
of trabecula septomarginalis? Could
there be a solution without using
a transannular patch supposing that
this pulmonary stenosis was secondary
to ventricular septal defect (VSD)?
We think that the ratio of residual
VSD is high because of the technique,
not the surgeon. During the repair of
VSD, pledgets are left on the right ven-
tricular side (needle is inserted from
the right ventricular side of VSD in
the classic method). With this method,
pressure (pressure gradient between
